Related references
Note: Only part of the references are listed.Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient
Ji Hoon Baang et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
CD169 and CD64 could help differentiate bacterial from CoVID-19 or other viral infections in the Emergency Department
Penelope Bourgoin et al.
CYTOMETRY PART A (2021)
Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy
Jonathan London et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Impact of complement and difference of cell-based assay and ELISA in determination of neutralization capacity against mumps and measles virus
Marija Brgles et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2021)
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
Shaukat Ali et al.
IMMUNOTHERAPY (2021)
SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis
Parisa Shiri Aghbash et al.
LIFE SCIENCES (2021)
Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency
Kazuhito Honjo et al.
CELL REPORTS MEDICINE (2021)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
A new coronavirus associated with human respiratory disease in China (vol 579, pg 265, 2020)
Fan Wu et al.
NATURE (2020)
Convalescent plasma therapy in patients withCOVID-19
Tugce Nur Yigenoglu et al.
JOURNAL OF CLINICAL APHERESIS (2020)
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
Ian Huang et al.
JOURNAL OF INTENSIVE CARE (2020)
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19
Thomas Hueso et al.
BLOOD (2020)
Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience
Kanta Subbarao et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Treatment for emerging viruses: Convalescent plasma and COVID-19
Bethany L. Brown et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Lymphopenia during the COVID-19 infection: What it shows and what can be learned
Soheil Tavakolpour et al.
IMMUNOLOGY LETTERS (2020)
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
Haoli Jin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
Victoria A. Avanzato et al.
CELL (2020)
SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition
Arne Sattler et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review
Ihsane Benlyamani et al.
CYTOMETRY PART A (2020)
A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma
Joanna L. Moore et al.
AMERICAN JOURNAL OF CASE REPORTS (2020)
Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow
O. Garraud et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE (2016)
Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
Darren M. Roberts et al.
JOURNAL OF AUTOIMMUNITY (2015)
Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity
B. Halassy et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study
Mathias Streitz et al.
TRANSPLANTATION RESEARCH (2013)